NMSS Partnership Targets Autoimmune Disease Research

Apr 12, 2021, 12:00 AM

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a NMSS partnership which targets autoimmune disease research.
Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how MS makes her feel part of a secret club of a minority who understand.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/